Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: Critical role of IL-12

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Adhikari, Anupam ^a   Gupta, Gaurav ^a   Majumder, Saikat ^a   Banerjee, Sayantan ^a   Bhattacharjee, Surajit ^a   Bhattacharya, Parna ^a   Kumari, Sangeeta ^b   Haldar, Subhadra ^b   Majumdar, Suchandra Bhattacharyya ^a   Saha, Bhaskar ^b   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; INTERLEUKIN 12; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNOMODULATION; INFECTION RESISTANCE; LEISHMANIA DONOVANI; LEISHMANIASIS; MALE; MOUSE; MYCOBACTERIUM; MYCOBACTERIUM INDICUS PRANII; NONHUMAN; PARASITE LOAD; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH1 CELL;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; CYTOKINES; IMMUNOTHERAPY; INTERLEUKIN-12; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NITRIC OXIDE; NONTUBERCULOUS MYCOBACTERIA; REACTIVE OXYGEN SPECIES; SPLEEN; TH1 CELLS;

LEISHMANIA DONOVANI; MUS; MYCOBACTERIUM; PROTOZOA;

EID: 84863615193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040265     Document Type: Article

References (32)

1. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873-882.
2. Coler RN, Reed SG, (2005) Second-generation vaccines against leishmaniasis. Trends Parasitol 21: 244-249.
3. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C, (1996) Reactivation of latent Leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183: 1501-1514.
4. Satoskar AR, Rodig S, Telford SR, Satoskar AA, Ghosh SK, et al. (2000) IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Eur J Immunol 30: 834-839.
5. Rodrigues V Jr, Silva da, Santana J, Campos Neto A, (1998) Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect Immun 66: 1233-1236.
6. Bogdan C, Vodovotz Y, Nathan CF, (1991) Macrophage deactivation by Interlukin-10. J Exp Med 174: 1549-1555.
7. Gupta G, Bhattacharjee S, Bhattacharyya S, Bhattacharya P, Adhikari A, et al. (2009) CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response. J Infect Dis 200: 1300-1310.
8. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B, (2004) Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 10: 540-544.
9. Reddi PP, Amin AG, Khandekar PS, Talwar GP, (1994) Molecular definition of unique species status of Mycobacterium w; a candidate leprosy vaccine strain. Int J Lepr Other Mycobact Dis 62: 229-236.
10. Zaheer SA, Mukherjee R, Ramkumar B, Misra RS, Sharma AK, et al. (1993) Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J Infect Dis 167: 401-410.
11. Gupta A, Geetha N, Mani J, Upadhyay P, Katoch VM, et al. (2009) Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route. Infect Immun 77: 223-231.
12. Singh IG, Mukherjee R, Talwar GP, Kaufmann SH, (1992) In vitro characterization of T cells from Mycobacterium w-vaccinated mice. Infect Immun 60: 257-263.
13. Alexander J, Bryson K, (2005) T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 99: 17-23.
14. Berman JD, Ksionski G, Chapman WL, Waits VB, Hanson WL, (1992) Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrob Agents Chemother 36: 1978-1980.
15. Davidson RN, Croft SL, Scott A, Maini M, Moody AH, et al. (1991) Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 337: 1061-1062.
16. Taylor A, Murray HW, (1997) Intracellular antimicrobial activity in the absence of interferon-γ: effect of interleukin 12 in experimental visceral leishmaniasis in interferon-γ gene-disrupted mice. J Exp Med 185: 1231-1239.
17. Chakkalath HR, Titus RG, (1994) Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol 153: 4378-4387.
18. Murray HW, (2000) Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. Int J Infect Dis 4: 158-177.
19. Little JR, Plut EJ, Kotler-Brajtburg J, Medoff G, Kobayashi GS, (1978) Relationship between the antibiotic and immunoadjuvant effects of amphotericin B methyl ester. Immunochemistry 15: 219-224.
20. Little JR, Wolf JE, (1987) Immunologic effects of Amphotericin B. Clin Immunol News 8: 183-185.
21. Sarthou P, Primi D, Cazenave PA, (1986) B cell triggering properties of a nontoxic derivative of amphotericin B. J Immunol 137: 2156-2161.
22. Arning M, Kliche KO, Heer-Sonderhoff AH, Wehmeier A, (1995) Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels. Mycose 38: 459-465.
23. Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C, (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284: 951-955.
24. Matsuo K, Hotokezaka H, Ohara N, Fujimura Y, Yoshimura A, et al. (2006) Analysis of amphotericin B-induced cell signaling with chemical inhibitors of signaling molecules. Microbiol Immunol 50: 337-347.
25. Satoskar AR, Rodig S, Telford SR, Satoskar AA, Ghosh SK, et al. (2000) IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Eur J Immunol 30: 834-839.
26. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
27. Azuma I, Yamamura Y, Fukushi K, (1968) Fractionation of mycobacterial cell wall Isolation of arabinose mycolate and arabinogalactan from cell wall fraction of Mycobacterium tuberculosis strain Aoyama B. J Bacteriol 96: 1885-1887.
28. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131-138.
29. Schreck R, Baeuerle PA, (1994) Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol 234: 151-163.
30. Gupta G, Bhattacharjee S, Bhattacharyya S, Bhattacharya P, Adhikari A, et al. (2009) CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response. J Infect Dis 200: 1300-1310.
31. Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, et al. (2002) Leishmania donovani suppresses activator protein-1 and NF-kB in host macrophages via ceramide generation: involvement of extracellular signal regulated kinase. Infect Immun 70: 6828-6838.
32. Dey R, Majumder N, Majumdar SB, Bhattacharjee S, Banerjee S, et al. (2007) Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Scand J Immunol 66: 671-683.